Time dependent impact of perinatal hypoxia on growth hormone, insulin-like growth factor 1 and insulin-like growth factor binding protein-3

被引:0
|
作者
Ömer Kartal
Seçil Aydınöz
Ayşe Tuğba Kartal
Taha Kelestemur
Ahmet Burak Caglayan
Mustafa Caglar Beker
Ferhan Karademir
Selami Süleymanoğlu
Mustafa Kul
Burak Yulug
Ertugrul Kilic
机构
[1] Istanbul Medipol University,Department of Physiology, Regenerative and Restorative Medical Research Center
[2] Haydarpasa Teaching Hospital,Department of Pediatrics, Gulhane Military Medical Academy
[3] Marmaris State Hospital,Department of Pediatrics
来源
Metabolic Brain Disease | 2016年 / 31卷
关键词
Perinatal hypoxia; Brain injury; Apoptosis; Serum GH; IGF-1; IGFBP-3 levels;
D O I
暂无
中图分类号
学科分类号
摘要
Hypoxic-ischemia (HI) is a widely used animal model to mimic the preterm or perinatal sublethal hypoxia, including hypoxic-ischemic encephalopathy. It causes diffuse neurodegeneration in the brain and results in mental retardation, hyperactivity, cerebral palsy, epilepsy and neuroendocrine disturbances. Herein, we examined acute and subacute correlations between neuronal degeneration and serum growth factor changes, including growth hormone (GH), insulin-like growth factor 1 (IGF-1) and insulin-like growth factor binding protein-3 (IGFBP-3) after hypoxic-ischemia (HI) in neonatal rats. In the acute phase of hypoxia, brain volume was increased significantly as compared with control animals, which was associated with reduced GH and IGF-1 secretions. Reduced neuronal survival and increased DNA fragmentation were also noticed in these animals. However, in the subacute phase of hypoxia, neuronal survival and brain volume were significantly decreased, accompanied by increased apoptotic cell death in the hippocampus and cortex. Serum GH, IGF-1, and IGFBP-3 levels were significantly reduced in the subacute phase of HI. Significant retardation in the brain and body development were noted in the subacute phase of hypoxia. Here, we provide evidence that serum levels of growth-hormone and factors were decreased in the acute and subacute phase of hypoxia, which was associated with increased DNA fragmentation and decreased neuronal survival.
引用
收藏
页码:827 / 835
页数:8
相关论文
共 50 条
  • [1] Time dependent impact of perinatal hypoxia on growth hormone, insulin-like growth factor 1 and insulin-like growth factor binding protein-3
    Kartal, Omer
    Aydmoz, Secil
    Kartal, Ayse Tugba
    Kelestemur, Taha
    Caglayan, Ahmet Burak
    Beker, Mustafa Caglar
    Karademir, Ferhan
    Suleymanoglu, Selami
    Kul, Mustafa
    Yulug, Burak
    Kilic, Ertugrul
    [J]. METABOLIC BRAIN DISEASE, 2016, 31 (04) : 827 - 835
  • [2] Developmental pattern of fetal growth hormone, insulin-like growth factor I, growth hormone binding protein and insulin-like growth factor binding protein-3
    Pirazzoli, P
    Cacciari, E
    DeIasio, R
    Pittalis, MC
    Dallacasa, P
    Zucchini, S
    Gualandi, S
    Salardi, S
    David, C
    Boschi, S
    [J]. ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION, 1997, 77 (02): : F100 - F104
  • [3] Insulin-like growth factor binding protein-3: Insulin-like growth factor independence comes of age
    Cohen, P
    [J]. ENDOCRINOLOGY, 2006, 147 (05) : 2109 - 2111
  • [4] Relationships Between Colorectal Cancer and Insulin, Insulin-like Growth Factor-1 and Insulin-like Growth Factor Binding Protein-3
    Moiseenko, A. B.
    Berstein, L. M.
    Belyaeva, A. V.
    [J]. EUROPEAN JOURNAL OF CANCER, 2011, 47 : S410 - S410
  • [5] In silico interaction of insulin-like growth factor binding protein 3 with insulin-like growth factor 1
    Jafari, Elham
    Gheysarzadeh, Ali
    Mahnam, Karim
    Shahmohammadi, Rezvan
    Ansari, Amir
    Bakhtyari, Hadi
    Mofid, Mohammad Reza
    [J]. RESEARCH IN PHARMACEUTICAL SCIENCES, 2018, 13 (04) : 332 - 342
  • [6] The effect of insulin-like growth factor-1 and insulin-like growth factor binding protein-3 in cavernous nerve cryoablation
    Bochinski, DJ
    Hsieh, PS
    Chen, KC
    Yeh, CH
    Nunes, L
    Lin, GT
    Lin, CS
    Spencer, M
    Deng, D
    Lue, T
    [J]. JOURNAL OF UROLOGY, 2003, 169 (04): : 313 - 313
  • [7] Variation in plasma insulin-like growth factor-1 and insulin-like growth factor binding protein-3: Genetic factors
    Morimoto, LM
    Newcomb, PA
    White, E
    Bigler, J
    Potter, JD
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2005, 14 (06) : 1394 - 1401
  • [8] Insulin-like growth factor-1 and insulin-like growth factor-binding protein-3 in women with premenstrual syndrome
    Rapkin, AJ
    Cedars, M
    Morgan, M
    Goldman, L
    [J]. FERTILITY AND STERILITY, 1998, 70 (06) : 1077 - 1080
  • [9] Insulin-like growth factor-1, insulin-like growth factor-binding protein-3, growth hormone, and mammographic density in the Nurses’ Health Studies
    Megan S. Rice
    Shelley S. Tworoger
    Bernard A. Rosner
    Michael N. Pollak
    Susan E. Hankinson
    Rulla M. Tamimi
    [J]. Breast Cancer Research and Treatment, 2012, 136 : 805 - 812
  • [10] Insulin-like growth factor-1, insulin-like growth factor-binding protein-3, growth hormone, and mammographic density in the Nurses' Health Studies
    Rice, Megan S.
    Tworoger, Shelley S.
    Rosner, Bernard A.
    Pollak, Michael N.
    Hankinson, Susan E.
    Tamimi, Rulla M.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2012, 136 (03) : 805 - 812